ASTRAZENECA ANNOUNCES PARTNERSHIP WITH ILLUMINA TO DEVELOP NEXT GENERATION GENE SEQUENCING PANEL FOR COMPANION DIAGNOSTIC TESTS
AstraZeneca today announced that it has entered into a collaboration with gene sequencing company, Illumina, Inc., to develop its next generation sequencing (NGS) platform for companion diagnostic tests applicable across AstraZeneca’s oncology portfolio.